Anixa Biosciences Inc (ANIX)
3.005
+0.16
(+5.44%)
USD |
NASDAQ |
May 10, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Net Income (TTM): -10.74M for Jan. 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | -10.74M |
| October 31, 2023 | -9.811M |
| July 31, 2023 | -10.60M |
| April 30, 2023 | -10.83M |
| January 31, 2023 | -12.09M |
| October 31, 2022 | -13.60M |
| July 31, 2022 | -14.13M |
| April 30, 2022 | -15.72M |
| January 31, 2022 | -14.58M |
| October 31, 2021 | -12.95M |
| July 31, 2021 | -11.16M |
| April 30, 2021 | -9.393M |
| January 31, 2021 | -9.634M |
| October 31, 2020 | -10.02M |
| July 31, 2020 | -9.882M |
| April 30, 2020 | -9.460M |
| January 31, 2020 | -9.358M |
| October 31, 2019 | -11.65M |
| July 31, 2019 | -14.86M |
| April 30, 2019 | -18.20M |
| January 31, 2019 | -17.04M |
| October 31, 2018 | -14.00M |
| July 31, 2018 | -10.48M |
| April 30, 2018 | -6.797M |
| January 31, 2018 | -5.258M |
| Date | Value |
|---|---|
| October 31, 2017 | -5.009M |
| July 31, 2017 | -4.271M |
| April 30, 2017 | -3.580M |
| January 31, 2017 | -5.013M |
| October 31, 2016 | -5.016M |
| July 31, 2016 | -5.261M |
| April 30, 2016 | -5.760M |
| January 31, 2016 | -6.724M |
| October 31, 2015 | -1.379M |
| July 31, 2015 | -3.240M |
| April 30, 2015 | -1.227M |
| January 31, 2015 | -2.240M |
| October 31, 2014 | -9.606M |
| July 31, 2014 | -9.380M |
| April 30, 2014 | -12.37M |
| January 31, 2014 | -11.60M |
| October 31, 2013 | -10.08M |
| July 31, 2013 | -9.014M |
| April 30, 2013 | -7.061M |
| January 31, 2013 | -5.462M |
| October 31, 2012 | -4.253M |
| July 31, 2012 | -5.184M |
| April 30, 2012 | -6.328M |
| January 31, 2012 | -6.738M |
| October 31, 2011 | -7.378M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-15.72M
Minimum
Apr 2022
-9.358M
Maximum
Jan 2020
-11.60M
Average
-10.83M
Median
Apr 2023
Net Income (TTM) Benchmarks
| CEL-SCI Corp | -31.05M |
| AIM ImmunoTech Inc | -28.96M |
| IGC Pharma Inc | -14.14M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Protalix BioTherapeutics Inc | 8.312M |